Journal
PEDIATRIC HEMATOLOGY AND ONCOLOGY
Volume 39, Issue 1, Pages 74-79Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/08880018.2021.1928802
Keywords
Combined immunodeficiency; hemophagocytic lymphohystiocytosis; HSV-1; Rubinstein Taybi syndrome; syndromic immunodeficiency
Categories
Ask authors/readers for more resources
Rubinstein-Taybi syndrome is an autosomal dominant disorder caused by variants in CREBBP or EP300, characterized by distinctive features, intellectual disability, and immunodeficiency. The clinical presentation is expanding to include complications such as autoinflammatory, autoimmune, and infectious conditions, and prompt treatment can reduce mortality rates.
Rubinstein-Taybi syndrome (RSTS) is an autosomal dominant disorder, caused by variants in CREBBP or EP300. Affected individuals present with distinctive craniofacial features, broad thumbs and/or halluces, intellectual disability and immunodeficiency. Here we report on one RSTS patient who experienced hemophagocytic lymphohystiocytosis (HLH) and disseminated herpes virus 1 ( HSV-1) disease. The clinical picture of RSTS is expanding to include autoinflammatory, autoimmune, and infectious complications. Prompt treatment of HLH and disseminated HSV-1 can lower the mortality rate of these life-threatening conditions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available